ArticleBreast (Edinburgh, Scotland)2025

Comparison of neoadjuvant and adjuvant chemotherapy for operable triple-negative breast cancer before the era of immune checkpoint inhibitors: A retrospective study from the Japanese National Clinical Database-Breast Cancer Registry.

Tomoe Taji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.